• Isoprinosine (Inosine Pranobex): Mechanistic Innovation a...

  2025-10-23

  This thought-leadership article provides a comprehensive, mechanistic, and strategic exploration of Isoprinosine (inosine pranobex) as a next-generation immunomodulatory agent for viral infections. Integrating the latest advances in herpesvirus biology, experimental validation, and translational applications, it offers actionable insights for researchers aiming to bridge the gap between bench and bedside in viral immunotherapy.

• Oseltamivir Acid: Advanced Influenza Neuraminidase Inhibi...

  2025-10-22

  Oseltamivir acid stands out as a precision influenza neuraminidase inhibitor that not only halts viral propagation but also empowers next-generation research in cancer metastasis inhibition and antiviral drug development. Discover optimized experimental workflows, troubleshooting strategies, and innovative applications that maximize the translational power of this versatile compound.

• DRB (HIV Transcription Inhibitor): Innovating RNA Polymer...

  2025-10-21

  DRB (5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole) stands out as a versatile transcriptional elongation and CDK inhibitor, enabling precise dissection of HIV transcription, cell cycle regulation, and antiviral mechanisms. Its unique solubility and mechanistic specificity make it indispensable for advanced workflows in HIV, cancer, and stem cell research.

168 records 12/12 page Previous First page 上5页 1112